Pr. Sébastien THUREAU
Fonction : Professeur des Universités - Praticien Hospitalier
Groupe : Quantif
Publications associées
- Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.
ESMO Open · 2023 - Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
Cancers (Basel) · 2023 - Prediction of brain tumor recurrence location based on multi-modal fusion and nonlinear correlation learning.
Comput Med Imaging Graph. · 2023 - Advances in PET and MRI imaging of tumor hypoxia.
Front Med (Lausanne). · 2023 - Preoperative Radiation Therapy for Chemorefractory Localized Inflammatory Breast Cancer.
Pract Radiat Oncol. · 2023 - ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases.
Technol Cancer Res Treat · 2023 - Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study.
Cancers (Basel) · 2022 - Synthetic MRI for Radiotherapy Planning for Brain and Prostate Cancers: Phantom Validation and Patient Evaluation.
Front Oncol · 2022 - Evaluation of a Dedicated Software « Elements™ Spine SRS, Brainlab® » for Target Volume Definition in the Treatment of Spinal Bone Metastases With Stereotactic Body Radiotherapy.
Front Oncol · 2022 - Radiotherapy of bone metastases.
Cancer Radiother · 2022 - Lung metastases radiation therapy.
Cancer Radiother · 2022 - Characterization of positioning uncertainties in PET-CT-MR trimodality solutions for radiotherapy.
J Appl Clin Med Phys · 2022 - Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors.
Q J Nucl Med Mol Imaging · 2022 - [Crisis situations: Ethical reflection on prioritization of care access in radiation oncology].
1Cancer Radiother · 2022 - [What dose escalation in the treatment of locally advanced non-small cell lung cancer?].
Cancer Radiother · 2022 - First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer.
First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer. · 2021 - Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy.
Cancers (Basel) · 2021 - Enjeux éthiques de la pratique des soins à visée palliative en oncologie radiothérapique [Ethical stakes in palliative care in radiation oncology].
Cancer Radiother · 2021 - Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
BMC Cancer · 2021 - Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review.
Front Oncol · 2021 - Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC.
Sci Rep · 2021 - Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence.
EJNMMI Res · 2021 - Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program.
Ther Adv Med Oncol. · 2021 - Evaluation of inter- and intra-fraction 6D motion for stereotactic body radiation therapy of spinal metastases: influence of treatment time.
Radiat Oncol. · 2021 - Histosurgical mapping of endoscopic endonasal surgery of sinonasal tumours to improve radiotherapy guidance.
Cancer Radiother · 2021 - Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images.
EJNMMI Phys · 2020 - Comparison of hypermetabolic and hypoxic volumes delineated on [18F] FDG an [18F] Fluoromisonidazole PET/CT in non-smal-cell lung cancer patients.
Mol Imaging Biol · 2020 - How to work together between nuclear medicine and radiotherapy departments ?
Cancer Radiother · 2020 - Benefits of positron emission tomography scans for the evaluation of radiotherapy.
Benefits of positron emission tomography scans for the evaluation of radiotherapy. · 2020 - Interest of positron emission tomography and magnetic resonance imaging for radiotherapy planning and control.
Cancer Radiother · 2020 - Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer.
Radiat Oncol · 2020 - Impact de la sarcopénie sur la survie globale et la survie sans progression après radiothérapie ou chimioradiothérapie pour le carcinome épidermoïde de la tête et du cou.
Cancer Radiother · 2020 - Tomographie par émission de positons (TEP) pour la radiothérapie : technique et innovations [PET technology: Latest advances and potential impact on radiotherapy].
Cancer Radiother · 2020 - Impact of positron emission tomography with computed tomography for image-guided radiotherapy.
Cancer Radiother · 2020 - Radiotherapy boost in patients with hypoxic lesions identified by F-FMISO PET/CT in non small cell lung carcinoma : can we expect a better survival outcome without toxicity ? (RTEP5 study).
EJNMMI · 2019 - Sub-cutaneous fat mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stageIV non-small cell lung cancer treated by nivolumab.
Oncoimmunology · 2019 - Comparison of hypermetabolic and hypoxic volumes delineated on 18FDG an 18Fmisonidazole PET-CT in non-small cell lung cancer patients.
Mol Imaging Biol · 2019 - Définition of target volume : when et how can the radiation oncologist use PET ?
Cancer Radiother · 2019 - Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before(chemo-)radiation.
PLoS One · 2019 - Imagerie inter- et intrafractions en radiothérapie stéréotaxique extracrânienne : quelles solutions pour quelles tumeurs ? [Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?].
Cancer Radiother · 2019 - Définition of target volume: when et how can the radiation oncologist use PET?
Cancer Radiother;23(6-7) :745-752. · 2019 - Inter and intrafraction imaging during stereotactic body radiation therapy : which solutions for which tumours ?
Cancer Radiother. S1278-3218(19)30389. · 2019 - Prophylactic nodal radiotherapy for breast cancer.
Cancer Radiother. S1278-3218(19)30387. · 2019